Restoring Insulin Secretion Pediatric Medication Study
Latest Information Update: 13 Dec 2021
Price :
$35 *
At a glance
- Drugs Insulin glargine (Primary) ; Metformin (Primary)
- Indications Prediabetic state; Type 2 diabetes mellitus
- Focus Therapeutic Use
- Acronyms RISE Peds
- 16 Jun 2021 Results from the three RISE study (NCT01779362, NCT01779375 and NCT01763346) assessing the effect of Liraglutide and metformin in adults would improve a-cell function beyond any potential effect of weight loss, published in the Diabetes Care.
- 15 Jun 2021 Results assessing the comparing the glycemic worsening between youth and adult RISE participants with IGT or recently diagnosed type 2 diabetes and identify baseline characteristics that predict glycemic worsening in each group, published in the Diabetes Care.
- 12 Jan 2021 Results examining the glucose response curves during an oral glucose tolerance test (OGTT) and their relationship to insulin sensitivity (IS) and B cell function in youth versus adults with impaired glucose tolerance or recently diagnosed type 2 diabetes published in the Diabetes Care